Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Conference item |
| Publié: |
American Thoracic Society
2018
|
| Résumé: |
|---|